135 related articles for article (PubMed ID: 15051531)
1. Instability of the biotin-protein bond in human plasma.
Bogusiewicz A; Mock NI; Mock DM
Anal Biochem; 2004 Apr; 327(2):156-61. PubMed ID: 15051531
[TBL] [Abstract][Full Text] [Related]
2. A biotin-protein bond with stability in plasma.
Bogusiewicz A; Mock NI; Mock DM
Anal Biochem; 2005 Feb; 337(1):98-102. PubMed ID: 15649381
[TBL] [Abstract][Full Text] [Related]
3. Biotin-protein bond: instability and structural modification to provide stability for in vivo applications.
Mock DM; Bogusiewicz A
Methods Mol Biol; 2008; 418():209-20. PubMed ID: 18287661
[TBL] [Abstract][Full Text] [Related]
4. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
Hoya K; Guterman LR; Miskolczi L; Hopkins LN
Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
[TBL] [Abstract][Full Text] [Related]
5. Release of biotin from biotinylated proteins occurs enzymatically and nonenzymatically in human plasma.
Bogusiewicz A; Mock NI; Mock DM
Anal Biochem; 2004 Aug; 331(2):260-6. PubMed ID: 15265731
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase biotinylation of antibodies.
Strachan E; Mallia AK; Cox JM; Antharavally B; Desai S; Sykaluk L; O'Sullivan V; Bell PA
J Mol Recognit; 2004; 17(3):268-76. PubMed ID: 15137036
[TBL] [Abstract][Full Text] [Related]
7. A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments.
Strassberger V; Trüssel S; Fugmann T; Neri D; Roesli C
Proteomics; 2010 Oct; 10(19):3544-8. PubMed ID: 20821733
[TBL] [Abstract][Full Text] [Related]
8. Biotinylation of antibodies.
Mao SY
Methods Mol Biol; 2010; 588():49-52. PubMed ID: 20012818
[TBL] [Abstract][Full Text] [Related]
9. Cell surface protein biotinylation for SDS-PAGE analysis.
Elia G
Methods Mol Biol; 2012; 869():361-72. PubMed ID: 22585500
[TBL] [Abstract][Full Text] [Related]
10. Protein biotinylation.
Alegria-Schaffer A
Methods Enzymol; 2014; 536():109-14. PubMed ID: 24423271
[TBL] [Abstract][Full Text] [Related]
11. Site-directed biotinylation of antibodies for controlled immobilization on solid surfaces.
Cho IH; Paek EH; Lee H; Kang JY; Kim TS; Paek SH
Anal Biochem; 2007 Jun; 365(1):14-23. PubMed ID: 17433247
[TBL] [Abstract][Full Text] [Related]
12. Quinone-based antibody labeling reagent for enzyme-free chemiluminescent immunoassays. Application to avidin and biotinylated anti-rabbit IgG labeling.
El-Maghrabey M; Kishikawa N; Harada S; Ohyama K; Kuroda N
Biosens Bioelectron; 2020 Jul; 160():112215. PubMed ID: 32339156
[TBL] [Abstract][Full Text] [Related]
13. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
14. Mild conditions for releasing mono and bis-biotinylated macromolecules from immobilized streptavidin.
Nguyen GH; Milea JS; Rai A; Smith CL
Biomol Eng; 2005 Oct; 22(4):147-50. PubMed ID: 15886055
[TBL] [Abstract][Full Text] [Related]
15. Artifactual detection of biotin on histones by streptavidin.
Bailey LM; Ivanov RA; Wallace JC; Polyak SW
Anal Biochem; 2008 Feb; 373(1):71-7. PubMed ID: 17920026
[TBL] [Abstract][Full Text] [Related]
16. Unexpected biotinylation using ATP-γ-Biotin-LC-PEO-amine as a kinase substrate.
Arora DP; Boon EM
Biochem Biophys Res Commun; 2013 Mar; 432(2):287-90. PubMed ID: 23399564
[TBL] [Abstract][Full Text] [Related]
17. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction.
Wu SC; Ng KK; Wong SL
Proteins; 2009 Nov; 77(2):404-12. PubMed ID: 19425108
[TBL] [Abstract][Full Text] [Related]
18. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation.
Luo Y; McDonald K; Hanrahan JW
Biochem J; 2009 Apr; 419(1):211-9, 2 p following 219. PubMed ID: 19053947
[TBL] [Abstract][Full Text] [Related]
19. Reversible biofunctionalization of surfaces with a switchable mutant of avidin.
Pollheimer P; Taskinen B; Scherfler A; Gusenkov S; Creus M; Wiesauer P; Zauner D; Schöfberger W; Schwarzinger C; Ebner A; Tampé R; Stutz H; Hytönen VP; Gruber HJ
Bioconjug Chem; 2013 Oct; 24(10):1656-68. PubMed ID: 23978112
[TBL] [Abstract][Full Text] [Related]
20. Current good manufacturing practices-compliant manufacture and measurement of biotin-labeled red blood cells.
Donnenberg AD; Kanias T; Triulzi DJ; Dennis CJ; Moore LR; Meyer EM; Sinchar D; Kiss JE; Normolle DP; Gladwin MT
Cytotherapy; 2019 Jul; 21(7):793-800. PubMed ID: 31097327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
